Zenagamtide
A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Tirzep
Novo Nordisk · Phase 1 · Recruiting · Enrollment 60
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Tirzepatide and Zenagamtide | Obesity + T2D | n/r | n/r | n/r | n/r |